Financial Year |
March 31 2023 |
Monetary Funds |
207,163,791.36 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
-- |
Accounts Receivable |
1,437,258,644.85 |
Advances to Suppliers |
88,772,735.48 |
Other Receivables |
23,927,145.68 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
2,849,368,181.20 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
42,057,934.51 |
Total Current Assets |
4,686,504,140.25 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
58,307,087.42 |
Investment Properties |
273,946,157.39 |
Fixed Assetes |
60,654,605.87 |
Under-construction Projects |
-- |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
14,205,613.98 |
R&D expenses |
-- |
Goodwill |
1,151,560.22 |
Long-Term Deferred and Prepaid Expenses |
3,603,605.26 |
Deferred Income Tax Assets |
4,075,518.25 |
Other Non-Current Assets |
-- |
Sub-Total of Non-Current Assets |
660,726,015.81 |
Total Assets |
5,347,230,156.06 |
Short-Term Loans |
1,604,096,941.07 |
Trading Financial liabilities |
-- |
Notes Payable |
220,303,784.96 |
Accounts Payable |
398,131,628.10 |
Accounts Received In Advance |
7,000,330.65 |
Employee Compensation Payable |
5,531,493.58 |
Taxes Payable |
11,251,031.60 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
31,621,417.93 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
34,481,807.71 |
Other Current Liabilities |
6,754,003.02 |
Sub-Total of Current Liabilities |
2,369,794,432.66 |
Long-term Loans |
315,373,626.55 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
2,418,784.72 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
348,244,136.74 |
Total Liabilities |
2,718,038,569.40 |
Paid-In Capital(Or Share Stock) |
1,256,531,571.00 |
Capital Surplus |
556,227,659.58 |
Surplus Reserve |
147,894,187.20 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
572,690,751.26 |
Minority Stockholder's Interest |
95,712,799.48 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,533,478,787.18 |
Owner's Equity(Stockholder's Equity) |
2,629,191,586.66 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
5,347,230,156.06 |